Details for New Drug Application (NDA): 203147
✉ Email this page to a colleague
The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 203147
Tradename: | RIZATRIPTAN BENZOATE |
Applicant: | Macleods Pharms Ltd |
Ingredient: | rizatriptan benzoate |
Patents: | 0 |
Pharmacology for NDA: 203147
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 203147
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 203147 | ANDA | Macleods Pharmaceuticals Limited | 33342-087 | 33342-087-07 | 30 TABLET, FILM COATED in 1 CONTAINER (33342-087-07) |
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 203147 | ANDA | Macleods Pharmaceuticals Limited | 33342-087 | 33342-087-12 | 10 BLISTER PACK in 1 CARTON (33342-087-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Feb 11, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Feb 11, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription